Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review
about
Interventions for bronchiectasis: an overview of Cochrane systematic reviewsInhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road aheadBronchiectasis in the Last Five Years: New DevelopmentsDiagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art reviewInhaled Antibiotics for Gram-Negative Respiratory InfectionsSuspecting non-cystic fibrosis bronchiectasis: What the busy primary care clinician needs to knowReview: Quality of Life in Children with Non-cystic Fibrosis Bronchiectasis.Eradication of Burkholderia cepacia Using Inhaled Aztreonam Lysine in Two Patients with Bronchiectasis.Impacts of Co-Existing Chronic Rhinosinusitis on Disease Severity and Risks of Exacerbations in Chinese Adults with BronchiectasisGenetics, diagnosis, and future treatment strategies for primary ciliary dyskinesia.Antimicrobial treatment of non-cystic fibrosis bronchiectasis.Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives.Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacinClinically Promising Biomarkers in Cystic Fibrosis Pulmonary Exacerbations.An update on pediatric bronchiectasis.Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry.The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis.The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases.Inhaled or nebulised ciprofloxacin for the maintenance treatment of bronchiectasis.An update on the pharmacotherapeutic management of lower respiratory tract infections.Update in Bronchiectasis 2014.The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.The microbiome and secondary lung disease in neuromuscular patients: Is it time to change our clinical practice?A pediatric disease to keep in mind: diagnostic tools and management of bronchiectasis in pediatric age.[Pseudomonas aeruginosa infections in chronic obstructive pulmonary disease : Role of long-term antibiotic treatment].Overview of systematic reviews assessing the evidence for shorter versus longer duration antibiotic treatment for bacterial infections in secondary care.Respiratory care in familial dysautonomia: Systematic review and expert consensus recommendationsNon-cystic fibrosis bronchiectasis in the elderly: current perspectives
P2860
Q24186645-97AF98A8-8C13-4A23-B9E0-6A6DF2EBC49CQ26822988-0395F6B5-4868-4E84-9198-CCD758893170Q28075732-4CC513A0-1AF3-4C8E-A073-63B90DCC2441Q28082500-DF4DB214-64FE-442C-8656-A43B81FC9B62Q28386160-0DCE1248-0421-449B-B623-DCF8434FC19EQ33577663-9624EDC6-CFC1-4B33-ADD6-9D0A72CCAF4EQ33720355-1416FE57-E1E8-4699-AA21-874D987CDB49Q34245276-82C8D6E4-BBFA-4B7B-BC6E-8AEED3781F32Q35764823-0E3B8F82-5621-41A5-9735-2504937CF30FQ36692961-1CF37284-EE28-42F9-A433-5A047F2FFD59Q38243206-EC226B94-F61B-4B62-82D0-E59EDCA8E4E4Q38569772-8E88BCE2-8B12-4683-BF86-EBA335F2B0A1Q38634682-A1A2561E-A07C-4B99-94E0-158415A12CD0Q38669996-424DBE2E-9778-4AFF-8EA9-68E8FE7DCA86Q38679480-F5ECE022-2D51-4BBF-B99A-16E7C4844BB9Q38799847-5094D416-77BD-416D-90EA-C46BAA49151DQ40093203-2A9F3634-CDD9-4D2B-97B7-437E000465AEQ40100000-8F569403-2E5F-40A2-92AA-196BE34C0B19Q40106308-EA57B62D-83B3-4920-BCE7-E4E911AE08C8Q40222424-57C54C3A-C2EE-43FD-ABDD-C7D2AA1D4438Q41122996-A6B3F227-CBB8-49DF-A757-B358796C3178Q47730320-C5D1DB2A-F3AE-4555-9630-95471984AB75Q47930034-D1819177-EA37-4BFD-8236-8445C2AEEC76Q48335145-51F2FB7C-AC54-4B67-B95D-620A7E84F9BAQ49567820-BD536116-C124-4A8C-8EC1-0231528D1E34Q54246802-5C58264F-0A07-47DF-AEEE-B979FBE30864Q57092123-582E96CD-1909-476B-B364-B4D647C446A7Q57646591-2DA5697A-5B43-4673-90C0-E39167BBFF3C
P2860
Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review
@ast
Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review
@en
Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review
@nl
type
label
Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review
@ast
Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review
@en
Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review
@nl
prefLabel
Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review
@ast
Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review
@en
Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review
@nl
P2093
P31
P1476
Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review
@en
P2093
P304
P356
10.1183/09031936.00018414
P407
P577
2014-08-01T00:00:00Z